Equities researchers at StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a research report issued on Thursday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock.
Titan Pharmaceuticals Stock Performance
Shares of NASDAQ TTNP opened at $6.13 on Thursday. The firm has a 50 day moving average of $5.83 and a 200 day moving average of $6.63. Titan Pharmaceuticals has a 12-month low of $4.24 and a 12-month high of $14.80.
Titan Pharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Titan Pharmaceuticals
- What Does Downgrade Mean in Investing?
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- What is the Euro STOXX 50 Index?
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Receive News & Ratings for Titan Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.